Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients

Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients

ObjectivesLittle is known about how various treatments impact the progression of interstitial lung disease (ILD) in rheumatoid arthritis (RA) patients. Here, we compared ILD progression in RA patients treated with Janus kinase inhibitors (JAKi) or biological disease-modifying anti-rheumatic drugs (b...

Full description

Saved in:
Bibliographic Details
Main Authors: Shota Kurushima, Tomohiro Koga, Masataka Umeda, Naoki Iwamoto, Ritsuko Miyashita, Takatomo Tokito, Daisuke Okuno, Hirokazu Yura, Hiroshi Ishimoto, Takashi Kido, Noriho Sakamoto, Yukitaka Ueki, Hiroshi Mukae, Atsushi Kawakami
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis
interstitial lung disease
RA-ILD
JAK inhibitors
methotrexate
epithelial-mesenchymal transition
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501146/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501146/full

Similar Items